ZFIN ChEBI: carboximidic acid

Relationships

is a type of: imidic acid organonitrogen compound

imidic acid organonitrogen compound Show first 5 Terms
has subtype: (1Z)-N-{(5S)-6-hydroxy-5-[(E)-(1-hydroxybutylidene)amino]hexyl}butanimidic acid (1Z)-N-{(5S)-6-hydroxy-5-[(E)-(1-hydroxydecylidene)amino]hexyl}decanimidic acid (1Z)-N-{(5S)-6-hydroxy-5-[(E)-(1-hydroxyhexylidene)amino]hexyl}hexanimidic acid (1Z,3R)-N-[(5S)-6-(acetyloxy)-5-{(E)-[(3R)-1-hydroxy-3-isocyanobutylidene]amino}hexyl]-3-isocyanobutanimidic acid (1Z,3R)-N-[(5S)-6-hydroxy-5-{(E)-[(3R)-1-hydroxy-3-isocyanobutylidene]amino}hexyl]-3-isocyanobutanimidic acid ... Show All 86 Terms

(1Z)-N-{(5S)-6-hydroxy-5-[(E)-(1-hydroxybutylidene)amino]hexyl}butanimidic acid (1Z)-N-{(5S)-6-hydroxy-5-[(E)-(1-hydroxydecylidene)amino]hexyl}decanimidic acid (1Z)-N-{(5S)-6-hydroxy-5-[(E)-(1-hydroxyhexylidene)amino]hexyl}hexanimidic acid (1Z,3R)-N-[(5S)-6-(acetyloxy)-5-{(E)-[(3R)-1-hydroxy-3-isocyanobutylidene]amino}hexyl]-3-isocyanobutanimidic acid (1Z,3R)-N-[(5S)-6-hydroxy-5-{(E)-[(3R)-1-hydroxy-3-isocyanobutylidene]amino}hexyl]-3-isocyanobutanimidic acid (2E,4E,8Z,11E)-2'-Hydroxy-N-isobutyl-2,4,8,11-tetradecatetraenamide (2S)-6-Amino-2-[(E)-(hydroxymethylene)amino]hexanimidic acid (E)-N,5-dihydroxy-3-methyl-N-[3-[(2S,5S)-5-(3-nitropropyl)-3,6-dioxopiperazin-2-yl]propyl]pent-2-enamide (E,Z)-N~2~,N~6~-bis[(3R)-1-hydroxy-3-isocyanodecylidene]-L-lysine (E,Z)-N~2~,N~6~-bis[(3R)-1-hydroxy-3-isocyanododecylidene]-L-lysine 1,8,15,22-Tetraazacyclooctacosane-2,9,16,23-tetrone 2,5-diamino-N-(1-amino-1-imino-3-methylbutan-2-yl)pentanamide 3-methyl-Butanamide 5S-hydroxynorvaline-S-Ile 6-Acetamidotridecane 17-hydroxymethyl-17-demethoxygeldanamycin acetimidic acid AM3102 Aminoethylcysteine ketimine Autoinducer III Bacillamidin G Bombyxamycin A BOX B Calothrixamide A Calothrixamide B carbohydroximic acid Cladosin A (major tautomer) Cladosin C (major tautomer) Cladosin D (major tautomer) Cladosin F Cladosin G Cornifronin A Cyclamenol D Cyclo Ala-Ala Cyclo-(L-Val-L-Leu) Cyclohexanecarboxamide Dehydro-gamma-sanshool Dichotomocej B Dichotomocej C Dietziamide A Dietziamide B formimidic acid FW05328-1 Glulisine A Halichomycin Herbimycin C isobutyramide isourea JBIR-150 JBIR-156 Kenalactam A Kenalactam B Kenalactam C Kenalactam D Kenalactam E Lanyuamide III Lobosamide A Lobosamide B Lobosamide C Micromonolactam Milacemide N,N'-1,3-Propanediylbis(2-propylpentanamide) N-(2-Amino-2-oxoethyl)tetradecanamide N-(2-methylpropyl)-2-methylbutenamide N-(hydroxymethyl)trifluoroacetamide N-Cyclohexylacetamide N-isopentyltridecanamide N-methylundec-10-enamide N-propyl arachidonoyl amine N1-(2-amino-2-oxoethyl)-2-(isopropylthio)acetamide N1-acetyl-N7-4′′-methyl-3′′-pentenoyl cadaverine N1-acetyl-N7-4′′-methyl-pentoyl cadaverine N1-acetyl-N7-n-hexanoyl cadaverine Neoherculin Neopellitorine A Nivelactam B Oleoyl Ethanolamide-d2 Piperazine-2-one S-1 methanandamide Sagamilactam Salinilactam Serinolamide C Talarazine A Trichocyclodipeptide B Trichocyclodipeptide C Vaccenic acid ethanolamide Show first 5 Terms

Phenotype

Phenotype resulting from carboximidic acid

Phenotype where environments contain carboximidic acid

Phenotype modified by environments containing carboximidic acid

Human Disease Model